Dr. Mengnan Tian, PhD
Head of In Vitro Neuroscience Ion Channels, Other Target Classes, RNA-Targeting Small Molecules, Oligonucleotide, Oligo Conjugates, Target Discovery, Target Validation, Biochemical Assay, Biophysical Assay, Cellular Assay, Biomarker, Drug Delivery, Organoid, Organ-On-Chip, Neurology, Neuropsychiatry, GPCRs
Dr. Mengnan Tian is the Head of In Vitro Neuropharmacology at WuXi AppTec, leading research efforts in central nervous system (CNS) pharmacology. Dr. Tian holds extensive expertise in CNS disorders and oligonucleotide drug discovery, and previously worked at Ionis Pharmaceuticals where he focused on oligonucleotide therapeutic screening and delivery platform development. Prior to entering the industry, Dr. Tian investigated synaptic plasticity and Alzheimer’s disease while completing postdoctoral training at Johns Hopkins University. Dr. Tian earned his PhD in Pharmacology from Vanderbilt University where he researched the molecular mechanisms of epilepsy. He also holds a BS in Biochemistry from Wuhan University.